Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men.

MLA

Melikian, Narbeh, et al. “Asymmetric Dimethylarginine and Reduced Nitric Oxide Bioavailability in Young Black African Men.” Hypertension (0194911X), vol. 49, no. 4, Apr. 2007, pp. 873–77. EBSCOhost, https://doi.org/10.1161/01.HYP.0000258405.25330.80.

APA

Melikian, N., Wheatcroft, S. B., Ogah, O. S., Murphy, C., Chowienczyk, P. J., Wierzbicki, A. S., Sanders, T. A. B., Jiang, B., Duncan, E. R., Shah, A. M., & Kearney, M. T. (2007). Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Hypertension (0194911X), 49(4), 873–877. https://doi.org/10.1161/01.HYP.0000258405.25330.80

Chicago

Melikian, Narbeh, Stephen B. Wheatcroft, Okechukwu S. Ogah, Cliona Murphy, Phillip J. Chowienczyk, Anthony S. Wierzbicki, Thomas A. B. Sanders, et al. 2007. “Asymmetric Dimethylarginine and Reduced Nitric Oxide Bioavailability in Young Black African Men.” Hypertension (0194911X) 49 (4): 873–77. doi:10.1161/01.HYP.0000258405.25330.80.